On March 1, 2022, MDClone, a digital health company, announced a $63 million Series C fundraise led by two new investors Warburg Pincus, a leading global growth investor, and Viola Growth, Israel’s leading growth fund, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed.
Naschitz Brandes Amir advised MDClone on the transaction. The team included partners Noga Devecseri Spira and Daniella Ben Shalom.
For more information, please see the company’s press release.